Pottorff A, Duarte P, Chow J, et al. - In an urban HIV clinic, the real-world implementation and results of extragenital nucleic acid amplification testing for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) was investigated. Researchers examined electronic health records for all patients 18 years or older with ≥ 1 outpatient visit to an HIV clinic in Dallas, TX from February 2016 to May 2019. Active interventions to increase testing followed extragenital nucleic acid amplification testing becoming available in February 2017. The study population consisted of 5,564 individual patients in the preintervention period (February 2016–January 2017), 5,067 in the intervention period (February 2017–August 2017), and 7,030 in the postintervention period (September 2017–May 2018). This study’s findings demonstrate that, in a large HIV clinic, increased GC/CT testing and detection was correlated with clinic-wide education and self-collection of extragenital specimens.